PMID: 4707021Jan 1, 1973

Dopamine and noradrenaline receptor stimulation: reversal of reserpine-induced suppression of motor activity

N E AndénT H Svensson


No abstract listed.


Sep 1, 1967·The Journal of Pharmacy and Pharmacology·N E AndénT Hökfelt
May 1, 1969·The Journal of Pharmacy and Pharmacology·G BartholiniA Pletscher
May 1, 1969·The Journal of Pharmacy and Pharmacology·G Bartholini, A Pletscher
Sep 1, 1969·The Journal of Pharmacy and Pharmacology·L L Butcher, J Engel
May 1, 1970·Life Sciences·N E AndénT H Svensson
May 15, 1972·Life Sciences. Pt. 1: Physiology and Pharmacology·J MajZ Kapturkiewicz
Jan 1, 1970·International Review of Neurobiology·J M Van Rossum
Nov 1, 1971·Journal of Pharmaceutical Sciences·A M Burkman, W K Van Tyle
Jan 1, 1969·Psychopharmacologia·T H Svensson, G Thieme
Dec 15, 1958·Acta Physiologica Scandinavica·A Carlsson, B Waldeck
Nov 1, 1959·Journal of the American Pharmaceutical Association·P N KAULE L WAY
Jan 1, 1962·Acta Physiologica Scandinavica·A Carlsson, M LINDQVIST


Oct 10, 2002·Synapse·Eric A StoneDavid Quartermain
Jul 19, 1978·Psychopharmacology·S L Handley, K V Thomas
Mar 29, 1977·Naunyn-Schmiedeberg's Archives of Pharmacology·C PycockC D Marsden
May 5, 1978·Naunyn-Schmiedeberg's Archives of Pharmacology·N E AndénG Trolin
Aug 15, 1977·Naunyn-Schmiedeberg's Archives of Pharmacology·T H Svensson, U Strömbom
Nov 1, 1982·Naunyn-Schmiedeberg's Archives of Pharmacology·N E AndénU Thornström
Nov 1, 1985·Naunyn-Schmiedeberg's Archives of Pharmacology·A RechesS Fahn
Jan 1, 1973·Journal of Neural Transmission·B Waldeck
Jan 1, 1990·Journal of Neural Transmission. General Section·N E Andén, M Grabowska-Andén
Jan 1, 1980·Journal of Neural Transmission·U Strömbom, T H Svensson
Jan 1, 1976·Acta neurochirurgica·P PopovicR Schaffer
Jan 1, 1975·Journal of Neural Transmission·U Strömbom
Jan 1, 1989·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·M Carlsson, A Carlsson
Aug 1, 1975·European Journal of Pharmacology·P Jenner, C D Marsden
Apr 1, 1976·European Journal of Pharmacology·R Horowski, H Wachtel
Jan 1, 1976·European Journal of Pharmacology·A DolphinC D Marsden
Oct 26, 1979·European Journal of Pharmacology·J DuteilE Assous
May 22, 1981·European Journal of Pharmacology·T NishikawaN Nagasaki
Mar 4, 1983·European Journal of Pharmacology·G PastorJ M Liebman
Jul 1, 1974·Journal of the Neurological Sciences·E Lycke, B E Roos
Jan 1, 1976·Neuropharmacology·I Shoulson, T N Chase
Feb 1, 1982·Physiology & Behavior·R M Chesire, P Teitelbaum
Oct 1, 1976·Pharmacology, Biochemistry, and Behavior·A DolphinC D Marsden
Oct 1, 1978·Pharmacology, Biochemistry, and Behavior·R J KatzB J Carroll
Nov 1, 1979·Pharmacology, Biochemistry, and Behavior·T Palfai, T J Walsh
Nov 1, 1985·Pharmacology, Biochemistry, and Behavior·P FayleP A Lafferty
Jun 1, 1985·Pharmacology, Biochemistry, and Behavior·T MoriN Kato
Jul 1, 1986·Pharmacology, Biochemistry, and Behavior·D Luttinger, M E Durivage
Sep 1, 1988·Pharmacology, Biochemistry, and Behavior·L P Gonzalez, J F Czachura
Jan 1, 1981·Pharmacology & Therapeutics·W H Gispen, R L Isaacson
Jan 1, 1994·Pharmacology & Therapeutics·D M Jackson, A Westlind-Danielsson
Jun 1, 1987·Behavioural Brain Research·M R PranzatelliS R Snodgrass
Mar 1, 1992·Neurochemistry International·R Horowski, I Runge
Jan 1, 1991·Progress in Neuro-psychopharmacology & Biological Psychiatry·M HascoëtJ Bradwejn
May 1, 1993·Progress in Neuro-psychopharmacology & Biological Psychiatry·H Ganry, M Bourin
Jan 1, 1983·Progress in Neurobiology·R H FishmanH L Klawans
Jan 1, 1980·Neuroscience·C Pycock
Jan 1, 1979·Progress in Neuro-psychopharmacology·R M PostW E Bunney
May 24, 2000·European Journal of Pharmacology·T J HudzikA J Cross
Sep 6, 2002·Pharmacology, Biochemistry, and Behavior·Eric A StoneDavid Quartermain
Mar 1, 1977·Clinical and Experimental Pharmacology & Physiology·R Dunstan, D M Jackson
Apr 1, 1975·The Journal of Pharmacy and Pharmacology·D M Jackson
Dec 3, 2011·Doklady Biological Sciences : Proceedings of the Academy of Sciences of the USSR, Biological Sciences Sections·G R KhakimovaM V Ugrumov
Dec 1, 1977·Postgraduate Medical Journal·G Curzon
Mar 22, 2006·Psychopharmacology·Sanneke A M van VlietIngrid H C H M Philippens
Sep 1, 1983·Naunyn-Schmiedeberg's Archives of Pharmacology·M G FeenstraA S Horn
Jan 1, 1982·Psychopharmacology·W C HolzR G Pendleton
Jan 1, 1992·Drug Metabolism Reviews·S Garattini
Sep 13, 1974·Brain Research·C D MarsdenD Tarsy
Sep 29, 2004·Synapse·Eric A StoneDavid Quartermain
Jan 1, 1981·Medicinal Research Reviews·S Fielding, H Lal
Apr 1, 1987·Pharmacology & Toxicology·K Gradin, B Persson
Jun 19, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Eric A StoneDavid Quartermain
Dec 1, 1977·The Journal of Pharmacy and Pharmacology·A DolphinB Testa
Feb 25, 1976·Naunyn-Schmiedeberg's Archives of Pharmacology·U Strömbom
Sep 1, 1981·Naunyn-Schmiedeberg's Archives of Pharmacology·L Pichler, W Kobinger
Aug 1, 1978·The Journal of Pharmacy and Pharmacology·U M Al-Shabibi, N S Doggett
Mar 1, 1985·Acta Pharmacologica Et Toxicologica·K GradinB Persson
Dec 1, 1973·The Journal of Pharmacy and Pharmacology·A J Pijnenburg, J M van Rossum
Apr 26, 1977·Naunyn-Schmiedeberg's Archives of Pharmacology·I Zebrowska-LupinaZ Kleinrok

Related Concepts

Brain Chemistry
Lentiform Nucleus Structure
Norepinephrine, (+, -)-Isomer
Receptors, Drug
Spinal Cord

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Synthetic Genetic Array Analysis

Synthetic genetic arrays allow the systematic examination of genetic interactions. Here is the latest research focusing on synthetic genetic arrays and their analyses.

Congenital Hyperinsulinism

Congenital hyperinsulinism is caused by genetic mutations resulting in excess insulin secretion from beta cells of the pancreas. Here is the latest research.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Epigenetic Memory

Epigenetic memory refers to the heritable genetic changes that are not explained by the DNA sequence. Find the latest research on epigenetic memory here.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Femoral Neoplasms

Femoral Neoplasms are bone tumors that arise in the femur. Discover the latest research on femoral neoplasms here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.